INFUSION DEVICE WITH PREFORMED SHAPE

Abstract: An infusion guidewire or catheter for introduction through a selected path in a patient's vascular system to a site in a blood vessel and for infusing a drug or agent into the blood vessel. An elongated tubular body extends between a proximal and a distal end having an infusion device lumen (16) formed therein extending to a plurality of infusion ports (18) formed in a distal infusion segment (26) of the elongated tubular body. The distal infusion segment (26) is pre-biased to assume an infusion configuration when positioned in a blood vessel that tends to present the infusion port toward the blood vessel wall in a low blood flow rate zone and defining a generally centrally disposed perfusion lumen for perfusing blood therethrough. A core wire or a guidewire (30) is inserted through said infusion device lumen from said proximal end into said distal infusion segment (26) for changing the configuration to allow the advancement of the infusion device through the patient's vascular system to a desired site in a blood vessel and for allowing the distal infusion segment (26) to assume said infusion configuration on withdrawal of the core wire or guidewire (30) from the distal infusion segment (26).

Description: INFUSION DEVICE WITH PREFORMED SHAPE BACKGROUND OF THE INVENTION Field of the Invention- The present invention relates to medical devices, e.g. catheters or guidewires commonly used in the placement of catheters, particularly in a patient's vascular system, and particularly to convertible infusion wires that can be used either as a guidewire or a catheter, and, in either case, may be used for infusion of drugs or agents in close proximity with a blood vessel wall or other body cavity during the course of or following an interventional procedure. Description of the Background Art-Medical catheters and guidewires are devices that can be navigated through narrow body passages, typically blood vessels, until the distal end section is in a desired location. Guide wires are typically used for introduction of a catheter over the guide wire. A physician controls the advancement and resulting position of the distal end of the guidewire by manipulations performed at the proximal end outside the body. Then the catheter is advanced over the guidewire, which may be left in place or withdrawn during a procedure using the guidewire. Catheters generally comprise hollow, flexible tubes that convey fluids, such as contrast agents or pharmacological drugs to or from a desired blυod vessel, organ or cavity through an internal catheter lumen. Cardiovascular balloon catheters have an inflatable balloon structure at the distal end for obstructing a blood vessel or, in the case of angioplasty, for expanding an occluded blood vessel. Cardiovascular guidewires and catheters sometimes have similar structures, but guidewires typically have a solid core and are dimensioned to be received within a catheter lumen. One very common guidewire construction has an elongated, flexible, helical coil having a proximal end and a distal end, the latter being inserted into the patient's vascular system. An internal "core wire" typically extends through the coil lumen with the proximal and distal ends of the core wire attached to the proximal and distal ends of the coil. In some helical coil guidewires used for cardiovascular purposes, the distal segment of the helical coil is J-shaped to provide improved steerability of the guidewire into various branches of a blood vessel, as shown, for example, in U.S. Patent No. 5,040,543. A core wire that can be advanced into the coil lumen is provided to adjust the size of die J-shape curve in the distal segment by moving the core wire distally (to straighten out the J) or moving the core wire proximally (to reform the J). The ability to control the J-shape of the distal end increases the facility by which the guidewire can be manipulated to select a desired blood vessel at branch points. In another application of a guidewire described in U.S. Patent No. 5, 122,136, a "guidewire" is constructed with a coil wire distal segment that may be advanced into an aneurysm and detached to effect thrombosis of the aneurysm cavity. The coil wire distal segment is itself pre-biased to assume a larger coil when released from a straight, surrounding micro-catheter lumen before it is inserted into the micro-catheter lumen and after it is introduced to the site of the aneurysm and advanced out of the lumen. In this configuration and use, the coiled wire distal segment does not function as a guidewire as otherwise described and referred to herein, since it can only be advanced to the site within the lumen of the micro-catheter. Some guidewires, called "convertible wires" or "infusion guidewires" are constructed of coiled wire defining a guidewire lumen with an outer sheath surrounding or within the coiled wire and are adapted for use both as guidewires and as infusion catheters as disclosed, for example, in U.S. Patent Nos. 5,178,158, 5, 184,627 and 5,211 ,636. Such convertible wires may be provided with a fixed or removable core wire within the lumen to stiffen it during advancement. Because of its narrow gauge, flexibility and column strength, the distal portion of a convertible wire can be advanced to a desired site in a blood vessel. Then the physician can advance a catheter over the convertible wire to the site. Depending on the design, the physician can remove the convertible wire from the catheter lumen or leave it in place while conducting a procedure with the catheter. Infusion of drugs or agents is typically effected from the proximal end, through the lumen and out through the distal end lumen opening or through side holes in the sheath or through the spaces between exposed turns of the coiled wire during or following the procedure using the catheter. Such convertible wires are often employed in conjunction with procedures to temporarily open a blood vessel blockage in order to both provide the guidewire function to introduce a treatment catheter and to also provide infusion at the site of treatment either during or following the treatment. The acute symptoms of blockage of a vein at a venous valve or a partially sclerosed and narrowed artery may be instigated by the presence of a soft obstruction or blood clot. In the venous and arterial blood vessels, such clots are referred to as an embolus or emboli and a thrombus or thrombi, respectively. Emboli and thrombi are characterized by a soft consistency that maintains a form and is resistant to dissolution in d e bloodstream or in water and entraps red blood cells. Recently formed blood clots stabilized in position as emboli and thrombi are soft and jelly-like in consistency and are readily penetrated but reform after the penetrating object is removed. Such blood clots may form for a variety of reasons in the vascular system and be released and flow until they block a partially occluded section of the blood vessel. When this clot blocks a vessel in the leg, for example, the resultant pain or loss of circulation requires its removal or dissolution. When blocking cardiac arteries manifesting atherosclerosis, the resulting ischemic episode triggers the symptoms of chest pain or heart failure, with respect to cardiac arteries, or a stroke or eyesight failure, if the carotid artery or its tributaries are blocked. The invasive removal or dissolution of soft blood clots and the opening of hard obstructions in blood vessels have become commonplace. To effect the initial opening of a soft obstruction, thrombolytic drugs or clot dissolving agents may be applied through an infusion catheter inserted into the clot to encourage the dissolution of the clot. For example, the infusion catheter disclosed in U.S. Patent No. 5,085,635 is proposed to be introduced over a guidewire and be used for infusion of thrombolytic drugs (as well as diagnostic agents, in other procedures) out side wall openings into contact with the blood vessel wall. In many instances it may not be necessary to proceed further with a separate procedure to enlarge die blood vessel, if the soft obstruction can be dissolved in situ and the occlusion is not severe. However, in the use of conventional infusion guidewires, convertible wires or catheters for introducing the dissolving agent, it is not always possible to maintain a concentration of the agent into the soft obstruction pressed against the blood vessel wall, where the infused agent would provide the most benefit. Laminar blood flow through the blood vessel washes the agent downstream before it may have the desired local effect. Similarly, in other infusion applications following balloon angioplasty or other procedures affecting the blood vessel wall, the laminar blood flow through the vessel washes a drug or agent emitted radially for treatment of the vessel wall downstream before it may have the desired local effect. In an approach to counter the loss of or more efficiently apply the drug or agent, specialized drug delivery dual balloon catheters have been developed to infuse drugs or agents against the vessel walls through holes in an outer balloon periphery or between two axially displaced, inflated balloons. The dual balloon catheters may have an inner through lumen for perfusion of blood while the balloons are in the inflated position for a matter of hours or days, as described, for example, in U.S. Patent No. 5,295,962. In the '635 patent, "pigtail" catheter designs of one or more loops having side wall openings are described, particularly in relation to rapid flush angiography for delivering contrast medium into a heart chamber. Such pigtail catheters are formed with the loop or loops formed in a planar configuration to minimize recoil of the catheter tip during the rapid and high pressure flush of the contrast medium into the heart chamber and blood vessels. It would be desirable to provide local delivery of lytic agents to a blood clot to magnify their therapeutic effects while minimizing the complications of systemically delivered lytic agents e.g. bleeding. Similarly, it would be desirable to apply and concentrate agents at a blood vessel wall following an angioplasty dilation for treatment of the localized injury to the vessel. Despite the advances and improvements in treatment that have been introduced in recent years, a need remains for an infusion guidewire and catheter that provides a simple and less expensive way to assure delivery of drugs or agents in the low flow rate region adjacent to the blood vessel wall and/or obstructions while allowing perfusion of the blood through the generally central lumen of the blood vessel. SUMMARY OF THE INVENTION In view of the various and sometimes inconsistent uses of the terms in the background art, and in order to simplify the understanding of the invention, it is desirable to define the term "infusion device" used in the following description of the preferred embodiments and in the claims as applicable to and embracing infusion guidewires, convertible wires, infusion catheters and micro-catheters as described above, wherein the distal infusion segment thereof provides for infusion of a drug or agent in proximity to a vessel wall or in intimate contact with a soft obstruction in accordance with the present invention. The term "obstruction" is employed in the remaining description of the preferred embodiments and in the claims to embrace and be the equivalent of a "soft obstruction" comprising a blood clot or embolus or thrombus and a "hard obstruction" comprising an occlusion formed of atherosclerotic plaque on the vessel wall. It is therefore a principal object of the present invention to provide an infusion device that makes intimate contact with and delivers drugs or agents for the dissolution of or otherwise treating a soft, recently formed obstruction in situ or contrast agent for radiologic identification of the soft obstruction. It is a further principal object of the present invention to provide an infusion device that makes contact with a vessel wall and delivers drugs and agents at the vessel wall for treatment thereof. It is a still further object of the present invention to provide such an infusion device having an infusion segment that expands to a preformed shape at the site of infusion for emitting the drug or agent in proximity to a vessel wall or within a soft obstruction of the vessel in the low blood flow rate region while allowing the laminar blood flow through the center of the vessel to continue. It is yet another object of the present invention to provide for the extension of the expanded infusion segment through a length that encompasses the length of the soft obstruction or vessel wall to be treated from the proximal end of the infusion device. These and other objects of the invention are realized in an infusion device for introduction through a selected path in a patient's vascular system to a site in a blood vessel and for infusing a drug or agent into the blood vessel comprising an elongated tubular body extending between a proximal and a distal end having a lumen formed therein extending from die proximal end to infusion ports formed in a distal infusion segment of the tubular body, the distal infusion segment formed to assume an infusion configuration when extended in a blood vessel that tends to present the infusion ports in a peripheral region of the blood vessel adjacent to the vessel wall in a low blood flow rate zone and defining a generally centrally disposed perfusion lumen for perfusing blood therethrough; and means for introducing said tubular body to allow its advancement through the patient's vascular system to a desired site in a blood vessel and for allowing the distal infusion segment to assume the infusion configuration on withdrawal of the introducing means from the distal infusion segment. In a preferred embodiment of the invention, the introducing means comprises a core wire for insertion through the lumen from the proximal end into the distal infusion segment for changing the configuration to allow the advancement of the tubular body through the patient's vascular system to a desired site in a blood vessel and for allowing the distal infusion segment to assume the infusion configuration on withdrawal of the core wire from the lumen extending through the distal infusion segment. Alternatively, the introducing means may be an introducing catheter surrounding the infusion device during insertion tiiat may be retracted proximally. In the preferred embodiment, the configuration of the distal infusion segment is in the form of a loose helix that is assumed upon withdrawal of the introducing catheter or core wire. The formation of the loose helical configuration may be encouraged by drawing on the proximal end of a traction line extending from the proximal to the distal end of the infusion device to compress and expand me loose helix. Moreover, d e length of die expanded, loose helical distal infusion segment may be controlled by manipulation of the introducing means and/or the traction line so that it conforms to die length of a soft occlusion or vessel wall injury. The present invention overcomes the problems associated with die prior art by providing an infusion device that may be dimensioned and otherwise constructed to have all of the advantages of a conventional infusion or convertible wire or infusion cad eter wherein the drug or agent is infused in die low blood flow rate zone adjacent to the blood vessel wall or hard obstruction and in intimate contact within a soft obstruction while blood perfusion is allowed in die generally central high blood flow rate zone of the blood vessel. In the infusion or convertible wire embodiment, because d e distal infusion segment can be straightened with the removable core wire and used as a guidewire, it can also be used for placement of otiier catheters, e.g. balloon catheters, pressure sensor, etc., by removing the standard fluid coupling from the proximal end and advancing the other catheter over the wire. The fluid coupling may be re-attached and infusion of the drug or agent commenced upon withdrawal of die core wire and expansion of the turns of the distal infusion segment during or following the procedure employing the odier catheter. The present invention is therefore applicable eidier to convertible wires or to infusion catheters, where the core wire may in fact be a guidewire. Advantageously, the invention may be used in place of a separate, larger diameter infusion catheter or the double balloon catheters and reduce the expense attendant to the operative procedure. BRIEF DESCRIPTION OF THE DRAWINGS Other objects, advantages and features of the present invention will be readily appreciated as die same becomes better understood by reference to me following detailed description when considered in connection with the accompanying drawings, in which like reference numerals designate like parts throughout the figures thereof and wherein: FIG. 1 is a conceptual view of an infusion device according to one embodiment of the present invention; FIG. 2 is a partially sectioned view of the distal end of the infusion device of FIG. 1 straightened for introduction through a blood vessel; FIG. 3 is a partially sectioned view of the distal end of the infusion device in accordance with an alternative embodiment of the present invention straightened for introduction dirough a blood vessel; FIG. 4 is a partially sectioned view of the distal end of die infusion device of FIG. 1 depicting its release into the expanded coil configuration upon retraction of a core wire; FIG. 5 is a partially sectioned view of the distal end of the infusion device of FIG. 1 depicting an alternative manner of introducing the infusion device and drawing it into die expanded helical configuration of a preferred length; FIGs. 6-9 are views illustrating d e method of introducing an infusion device, particularly a convertible wire, of the present invention into a soft obstruction and delivering drugs or agents into the obstruction and into proximity with the side wall of the blood vessel while allowing perfusion of blood centrally through die vessel; and FIGs. 10-13 are views illustrating the mediod of introducing an infusion device, particularly an infusion catiieter, of the present invention into a soft obstruction and delivering drugs or agents into the obstruction and into proximity with the side wall of the blood vessel while allowing perfusion of blood centrally through the vessel. The figures are not necessarily to scale. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Turning first to FIGs. 1 and 2, they depict the construction of an infusion device 10 in accordance widi one embodiment of the present invention in the relaxed, coiled, and in die straightened configurations of the distal infusion segment. The outer surface of the main body of infusion device 10 is a close or open wound, coiled wire 20 (as partially shown in FIG. 1 at the distal end tiiereof) covered by an outer sheath 14. A syringe or other pump system may be sealingly coupled to die proximal end of infusion device 10 by a standard Touhy-Borst connector 12 as shown in FIG. 1. Introduction of ie infusion fluid (a tiierapeutic drug or dissolving or contrast agent or die like) is preferably dirough the proximal opening of the coiled wire lumen within the connector 12. In the preferred mode, and not to be deemed as limiting of the invention, d e infusion fluid is loaded into a syringe (not shown) in the normal fashion and is pressurized with manual force applied to die tiiumb knob attached to a piston (not shown) or into a pumping system. Touhy-Borst connector 12 can be removed from the proximal end 24 of the guidewire 10 to allow die infusion device 10 to function as an ordinary guidewire using a removable core wire 30 to facilitate placement of other catheters as described in die above-referenced '636 patent. A solid, radiopaque distal tip 22 is attached to the distal end of coiled wire 20 in the manner known in the art by welding, brazing, soldering, etc. The lengtii of die straight section of the infusion device 10 between d e distal end of die distal infusion segment 26 and d e distal tip 22 may vary, depending on die application as eiti er a convertible wire or strictly as an infusion catheter. The pressurized infusion fluid is conveyed through the inner lumen 16 of infusion device 10 to be emitted from a series of n infusion ports 18, - 18„ in the outer sheath 14 in die distal infusion segment 26 when the core wire 30 is retracted dierefrom. The distal infusion segment 26 may be formed into a loose, expanded helical coil configuration 32 by winding die coiled wire 20 about a mandrel before or after it is covered witii sheath 14. The expanded helical configuration 32 defines a low tension spring of a number of spring coil turns surrounding a generally centrally disposed blood flow lumen 40 when it is not straightened by full insertion of die core wire 30. The infusion ports 18 ; - 18 π may be formed by slitting, puncturing or laser drilling die sheath 14 in die distal infusion segment 26. The infusion ports 18. - 18„ are then directed either toward the blood vessel wall or generally in die low blood flow peripheral region of the blood vessel when d e distal infusion segment 26 is released and allowed (or encouraged as described below in reference to FIG. 5) to form the loose expanded helical configuration 32. A minority of the infusion ports 18, - 18„ may be aimed centrally, depending on their location and die shape of the helical turns. Alternatively, the infusion ports 18, - 18„ may be formed in the outer exposed periphery of d e turns of the expanded helical configuration 32. The coiled wire 20 terminates at the proximal end 24 witiiin the Touhy- Borst connector 12 by a proximal lumen opening (not shown) for receiving the infusion fluid. The lumen opening also receives the removable core wire 30 (shown in FIGs. 2-4) which may be extended d e length of the guidewire lumen 16 to contact d e distal tip 22 and straighten out die distal infusion segment 26 as shown in a partially sectioned view of the first preferred embodiment of the present invention in FIG. 2. As shown in FIG. 2, the interior lumen 16 of die infusion device 10 contains the solid, tapered core wire 30 terminating in a free end 34 bearing against the distal tip 22 so tiiat die force applied from the proximal end straightens out die loose coil configuration 32. The handling characteristics of infusion device 10 may be improved by tapering solid core wire 30 beginning at a point proximal to the distal tip 34. Although FIGs. 1 and 2 depict a series of infusion ports 18, - 18„ formed in die outer sheatii 14, it will be understood tiiat in a further alternative, the outer sheath 14 may be replaced by an inner sheath with die infusion ports 18, - 18„ formed tiierein. Or the sheath 14 may be a polymer coating filling the gaps between the turns of the coiled wire 20 with die infusion ports 18, - 18„ formed by openings in the coating between turns of the coiled wire 20 in the distal infusion segment. Alternatively, die sheath 14 may be entirely removed along the distal infusion segment 26 so that the infused drug or agent may be allowed to escape dirough die gaps between the coiled wire turns forming infusion ports 18, - 18„. Turning to FIG. 3, it depicts a variation on tiiis second embodiment of die invention wherein the outer sheath 14 is replaced by an inner sheath 36 terminating where the distal infusion segment 26 begins. The closely wound turns of the coiled wire 20 are somewhat expanded in die distal infusion segment 26 as depicted to form a spiral gap through the lengtii of the distal infusion segment 26. It will be understood tiiat the tight winding may be retained in the distal infusion segment 26 since d e gap widtii may expand witii the release and expansion of die distal segment 26 into the unrestrained, loose expanded helical configuration 32. FIG 4 is a partially sectioned view of the distal end of the infusion device of FIG. 1 depicting its release from the straightened position of FIG. 2 into an expanded spiral coil, infusion configuration 32 through the length of die distal infusion segment 26 and in relation to a blood vessel wall 50. The core wire 30 is shown after wididrawal from die coiled wire lumen 16 of the distal infusion segment 26. The expanded helical configuration 32 may have an outer coil diameter on the order of 3-4 times die outer diameter of the coiled wire 20, which itself may have an outer diameter on the order of 0.014 - 0.038 inches, and die helical turns may roughly expand to conform to die diameter of die blood vessel lumen 52. The spiral coil expansion into die helical infusion configuration 32 creates a blood perfusion lumen 40 inside d e coil turns that is disposed centrally in a blood vessel to allow and direct the laminar flow of blood dierethrough in the direction of arrows 54 (or the reverse direction). At die same time, d e orientation of the infusion ports 18, - 18 B formed in d e outer sheath 14 circumferentially on the outside of die spiral coil infusion configuration 32 distributes d e infused drug or agent into die vicinity of the interior wall of the blood vessel 50 or in die adjacent region. In this manner, die drug or agent is distributed into the low blood flow rate, boundary layer region and is kept there for a longer period to treat a damaged vessel wall either in a stand alone procedure or following an earlier procedure, e.g. an angioplasty or atiierectomy procedure using a separate balloon catheter previously introduced over d e straight infusion device 10. The overall length and number of infusion coil turns formed in die loose, expanded helical configuration 32 of d e distal infusion segment 26 may be varied by selectively retracting the core wire 30. Infusion fluid may be delivered dirough die lumen 16 witii d e core wire 30 in place in such selective partial retraction. The length of the expanded helical configuration 32 may be adjusted to fit die length of die obstruction or vessel wall into or toward which the infusion fluid is delivered. FIG. 5 is a similar, partially sectioned view of the distal end of the infusion device of FIG. 1 depicting an alternative manner of introducing it and of drawing die distal infusion segment 26 into die expanded helical configuration of a preferred lengdi. In this variation, an introducer catiieter 48 is advanced to die site of treatment in the vascular system, and the infusion device 10 including die distal infusion segment 26 is tiien introduced down die lumen of the introducer catiieter 48. Alternatively, botii are introduced togetiier to d e treatment site. Any conventional introducer catiieter 48 or sheath may be employed for die purpose of straightening and guiding die infusion device 10 to die desired position, in a manner well known in the art. The introducer catiieter 48 may then be witiidrawn as shown in Figure 5 to allow the distal infusion segment 26 to assume its unrestrained expanded, loose helical configuration 32. As with use of die core wire 30, die partial withdrawal of die introducer catiieter 32 may be used to adjust die overall length of die expanded, loose helical configuration 32 to match die length of a soft obstruction or vessel wall injury. In the further embodiment of the invention depicted in FIG. 5, a fine traction line 60 that may be used to aid in die formation of the helical configuration 32 and adjust its length. The traction line 60 extends the length of the coiled wire lumen from the proximal end 24 of the infusion device 10 and out one of the proximal infusion ports 18 or an especially positioned line exit port 28 and then alongside the outer sheath 14 and is attached to the distal tip 22 (or just past die distal turn of the expanded helical configuration 32). As shown in Figure 6, the turns of the of the distal infusion segment 26 are pulled togetiier tighdy by tension applied to die traction line to draw the distal infusion segment 26 into the fully expanded helical configuration 32. During introduction, die distal infusion segment 26 is straightened witiiin the introducer catiieter 48 (or by die core wire 30) as described above. Altiiough not shown, it will be understood tiiat when the distal infusion segment 26 is straightened, die traction line 60 may be spirally wound about die outer sheath 14 between die exit port 28 and die tip attachment point. Upon advancement out the introducer catiieter lumen, the distal infusion segment 26 assumes d e unrestrained expanded, loose helical configuration 32 described above. The traction line 60 may tiien be pulled upon from die proximal end to assist d e formation of the expanded helical configuration 32 and to control its length and die spacing of adjacent turns by die application of compressive force that tightens the helical configuration 32. This assistance may be helpful even if the distal infusion segment has been preformed or pre-biased to assume d e expanded helical shape of the infusion coil configuration 32 when unrestrained. As shown in FIG. 5, the traction line 60 traverses alongside die helical configuration 32 and back into only die exit port 28. It will be understood that die traction line 60 may be inserted through several of the infusion ports 18 s aligned so that when tensile force is applied, die distal end 22 is pulled proximally, and die expanded helical configuration 32 is encouraged to form. It will also be understood tiiat die traction line 60 may be tiireaded through one or more of the spacings between the exposed coiled wire turns in d e embodiment of FIG. 3 to provide die compressive force when retracted, The infusion device 10 may be constructed by any of die known methods in monofilar and in multi-filar coiled wire windings and in one or more coaxial coils of circular or rectangular cross-section wire around an inner lumen 16 in a manner shown, for example, in the above-referenced '636, '627 and ' 158 patents. For simplicity of illustration, a monofilar, circular cross-section coiled wire 20 is depicted in die figures. In any of the depicted embodiments, coiled wire 20 is preferably a spring coil of stainless steel wire which is wound with a constant or variable pitch. However, a memory metal, e.g a Ni-Ti alloy or other memory material, may also be used to form the loose expanded helical configuration 32 at a transition temperature tiiat may, for example, be body temperature. In such a case, die elevation of the temperature of the distal infusion segment 26 from room to body temperature effects the change from straight to coiled configuration upon removal of die stiffening core wire 30. The temperature of the wire may also be elevated by die use of otiier energy sources such as by passing an electrical current through the wire. To return to the straight configuration of FIG. 2, it may be desirable to infuse a low temperature saline to cool the memory metal alloy below die transition temperature. The outer and inner sheaths 14 and 36 are only illustrative of a variety of sheath configurations tiiat may be employed, e.g. tiiose disclosed in die above- referenced '636, '627 and ' 158 patents. The sheatiis 14 and 36 may be fabricated as tubes inserted over or within die lumen 16 of die coiled wire 20 or may be coatings or heat shrunk tubings applied to die coiled wire 20 in a manner well known in the art. Any of the well known materials used in fabrication of guidewires and catheters may be used for die tiiin, non-porous and high pressure sheaths 14 and 36, including pplyetiiylenes, uretiianes, silicone rubber or PTFE compounds, etc. As indicated above, die present invention is also applicable to the design of infusion catheters or micro-catiieters having a somewhat larger overall diameter and often having a single lumen or multiple lumens for an inflatable balloon or sensor or other feature. Such catheters may or may not be reinforced witii one or more coiled wires or hypo tubes as is well known in the art. Such catiieters may be introduced into die vasculature by using an over-the-wire or monorail type insertion technique. For example, the single lumen infusion catheter disclosed in die above referenced '635 patent may be modified at the distal infusion segment in accordance with d e present invention. The single lumen infusion catiieter of die '635 patent has a self-sealing distal end opening to d e single lumen to allow advancement over a previously advanced guidewire. In such an application of the present invention to a larger diameter infusion catheter, the distal tip 22 depicted in the figures may be replaced by die self-sealing distal tip valve of the '635 patent to take advantage of die over the wire advancement. FIGs. 6-9 are views illustrating a method of introducing any one of die embodiments of the infusion device 10 of the present invention into a soft obstruction 56 and a hard obstruction 58 in the blood vessel 50 and delivering drugs or agents into die soft obstruction 56 and into proximity witii die side wall of d e blood vessel 50 while allowing perfusion of blood centrally dirough the coil lumen 40. In FIG. 6, the distal infusion segment 26 of die guide wire 10 is straightened and advanced witii die core wire 30 in the coiled wire lumen 16 past a narrowing or partial occlusion on the walls of the blood vessel 50 and toward the soft obstruction 56. In FIG. 7, die distal tip 22 is passed through the soft obstruction 56 to position the distal infusion segment 26 midway through the obstruction 56. The positioning may be aided by use of conventional fluoroscopy and by tracking radiopaque markers formed in the guidewire 10 at die ends of die distal infusion segment 26 in a manner well known in the art. In FIG. 8, die core wire is retracted (and die line 60 is pulled, if present or the memory metal reacts to the body temperature, if used), and the helical configuration 32 is formed. The expansion of die infusion coil helix forces the coil turns into the soft obstruction, helping to press it toward the wall of the blood vessel 50 and to increase the surface area to be treated by d e infused dissolving agent. Then, die dissolving agent may be infused into the pressed soft obstruction at a slow rate while the blood is allowed to flow through the infusion coil lumen 40 in the same manner as described above witii respect to FIG. 4. The slow infusion of the dissolving agent into die obstruction and in the region of low blood flow rate, provides for a rapid dissolution, using minimal amounts of dissolving agent. After the obstruction 56 is dissolved, die core wire 30 is advanced to straighten the distal infusion segment 26 as shown in FIG. 9, and die infusion device 10 is tiien withdrawn. FIGs. 10-13 depict die same steps of FIGs. 6-9 but using the infusion device of die present invention specifically as a single lumen infusion catheter 10 wherein the catheter is advanced over a guidewire 42 previously advanced tiirough the obstructions 58 and 56. In this configuration, a distal end self sealing valve 44 is substituted for die solid distal tip 22, and die guide wire 42 penetrates the valve 44 during advancement of die infusion catiieter 10. Such a self-sealing valve 44 with tiiree flap leaflets is disclosed in die above-referenced '635 patent, incorporated by reference herein. In FIG. 11 , die distal end of die catiieter is passed through die soft obstruction 56 to position the distal infusion segment 26 midway through die obstruction 56. The coil configuration 32 is formed by retraction of die guidewire 42 in FIG. 12 and actuation of die pull line 60, if present, or die operation of the memory metal in response to a change in temperature, if eitiier are used. After the infusion is completed, the guidewire 42 is again advanced past d e distal infusion segment 26 to straighten it. and die guidewire 42 and catheter body are withdrawn. The same method steps may be employed to advance d e distal infusion segment 26 into position witii respect to a vessel wall injury. The method is especially applicable after a balloon angioplasty or atiierectomy procedure has compressed or excised die hard obstruction but left the expanded or cleared vessel wall injured by die tiierapy. In this situation, it is often necessary to infuse drugs into the vessel wall to freat die injury response. The infusion device of die present invention may be dimensioned and configured as a convertible wire and used as d e guide wire for the angioplasty or atiierectomy catheter and tiien used in the manner described to infuse d e drug. In die case where the distal infusion segment is formed with a memory metal, e.g. a Ni-Ti alloy that assumes die helical configuration 32 at an elevated temperature, it will be understood tiiat die metiiod steps depicted in FIGs. 6-9 and 10-13 may include the further steps of infusing a cooling fluid, e.g. cooled saline, down die lumen 16 during introduction of the infusion device to keep die coiled wire 20 from assuming the helical configuration 32 until the position of FIGs. 7 and 11. Then, to return to the straight shape of FIGs. 9 and 13, it may be necessary to again inject a cooling fluid to aid in straightening d e distal infusion segment 26 during withdrawal of the infusion device. Aldiough die preferred embodiments depict a single, distal, infusion segment 26, it will be understood that more than one such infusion segment as described above may be formed along the length of the infusion device body. Moreover, it will be understood tiiat the distal infusion segment as described above in its various embodiments refers to any such infusion segment located anywhere along die lengtii of the infusion device body distal to d e proximal end tiiereof and not necessarily at die location generally depicted in the figures. While a number of preferred embodiments of the invention and variations thereof have been described in detail, otiier modifications and metiiods of using and medical applications for the same will be apparent to those of skill in die art. Accordingly, it should be understood tiiat various applications, modifications, and substitutions may be made of equivalents without departing from the spirit of the invention or the scope of the claims. PARTS LIST FOR FIGS. 1-13 infusion device 10 Touhy-Borst connector 12 outer sheath 14 inner lumen 16 n infusion ports 18, - 18 π coiled wire 20 distal tip 22 proximal end 24 distal end infusion segment 26 core wire 30 loose, expanded helical infusion coil configuration 32 free end 34 inner sheath 36 blood perfusion lumen 40 guide wire 42 distal valve 44 introducer catheter 48 blood vessel 50 blood vessel lumen 52 laminar blood flow arrows 54 soft obstruction 56 hard obstruction 58 traction line 60

Claims: CLAIMS 1. An infusion device for introduction tiirough a selected patii in a patient's body to a desired infusion site in a blood vessel and for infusing a drug or agent into the peripheral low blood flow rate region adjacent die blood vessel wall comprising: an elongated tubular body extending between a proximal end and a distal end having a an infusion lumen formed tiierein extending from the proximal end to a plurality of infusion ports formed in, and distributed along die length and around die circumference of an elongated distal infusion segment of d e tubular body distal to a proximal straight segment of the tubular body; means for forming the distal infusion segment to assume an expanded helical coil infusion configuration of at least two turns extending axial ly and outwardly from die proximal straight segment when positioned at a desired infusion site in a blood vessel, the expanded helical coil infusion configuration providing a generally centrally disposed higher flow rate perfusion lumen for perfusing blood centrally therethrough and locating the plurality of infusion ports in the peripheral low blood flow rate region of die blood vessel, such tiiat at least a first portion of the plurality of infusion ports face outward toward the vessel wall, a second portion of the plurality of infusion ports face axialty toward adjacent turns of die expanded helical coil, and a tiiird portion of the plurality of infusion ports face inward toward die perfusion lumen; and introducing means for altering said expanded helical coil infusion configuration of said distal infusion segment to allow its advancement through die patient's vascular system to die desired infusion site in a blood vessel and for allowing die distal infusion segment to assume said infusion configuration on withdrawal of said introducing means from die distal infusion segment. 2. The infusion device of Claim 1 wherein said distal infusion segment of said elongated tubular body further comprises: an elongated coiled wire surrounding said infusion lumen; an elongated sheath enclosing said elongated coiled wire for sealing said infusion lumen: and wherein: said plurality of infusion ports are formed as a plurality of openings in said sheath in said distal infusion segment for allowing passage of said infusion fluid dieredirough and into die low blood flow rate region of a blood vessel adjacent to die blood vessel wall. 3. The infusion device of Claim 2 wherein said elongated coiled wire and sheath are pre-biased to form said expanded helical coil infusion configuration in said distal infusion segment when said introducing means is withdrawn from said distal infusion segment. 4. The infusion device of Claim 3 wherein: said infusion configuration comprises a loosely expanded helical coil configuration having an inner perfusion lumen formed inside the turns of the helical coil; and said plurality of infusion ports are formed as openings in the sheath around die turns of die helical coil configuration for allowing infusion in the peripheral region of the body cavity or vessel. 5. The infusion device of Claim 1 wherein said elongated tubular body further comprises: an elongated, coiled wire extending from said proximal to said distal end and surrounding said infusion lumen; an elongated sheath enclosing said elongated coiled wire extending from said proximal end to said distal infusion segment for sealing said infusion lumen to said distal infusion segment; and wherein: said plurality of infusion ports are formed as the separations between adjacent turns of said elongated coiled wire extending through said distal infusion segment for allowing passage of said infusion fluid therethrough. 6. The infusion device of Claim 1 wherein said elongated tubular body further comprises: an elongated coiled wire extending from said proximal to said distal end and surrounding said infusion lumen, said elongated coiled wire pre-biased to form said helical coil infusion configuration [of at least one turn] in said distal infusion segment when said introducing means is withdrawn from said distal infusion segment. 7. The infusion device of Claim 6 wherein said elongated tubular body further comprises: an elongated traction line attached to said elongated coiled wire distal ly to said distal infusion segment and operable from the proximal end of said elongated tubular body to apply tension along said distal infusion segment to urge die formation of said expanded helical coil infusion configuration upon withdrawal of said introducing means from said distal infusion segment and to adjust die length of the helical coil infusion configuration. 8. The infusion device of Claim 1 wherein said elongated tubular body further comprises: an elongated coiled wire surrounding said infusion lumen in said distal infusion segment constructed of a temperature dependent memory material for assuming an expanded helical coil configuration when said introducing means is withdrawn from said distal infusion segment and when exposed to a temperature change at a desired infusion site in a blood vessel to provide said centrally disposed blood perfusion lumen. 9. The infusion device of Claim 1 wherein said elongated tubular body further comprises: an elongated traction line attached to said elongated tubular body distally to said distal infusion segment and operable from die proximal end of said elongated tubular body to apply tension to said distal infusion segment to urge the formation of said infusion configuration upon retraction of said core wire. 10. The infusion device of Claim 1 wherein said introducing means further comprises: a core wire for insertion through said infusion device lumen from said proximal end into said distal infusion segment for changing said infusion configuration to allow the advancement of said infusion device body tiirough the patient's vascular system to a desired site in a blood vessel and for allowing said distal infusion segment to assume said infusion configuration on withdrawal of said core wire from said distal infusion segment. 11. The infusion device of Claim 1 wherein said introducing means further comprises: an introducer catiieter having a lumen dimensioned to receive said elongated infusion body including said distal infusion segment for changing said infusion configuration to allow the advancement of said infusion device body through die patient's vascular system to a desired site in a blood vessel and for allowing said distal infusion segment to assume said infusion configuration on relative displacement of said introducer catiieter core wire from said distal infusion segment. 12. The infusion device of any of die Claims 1 , 2, 5, 6, 8 or 9 wherein: said infusion device is formed as an infusion guidewire adapted to be introduced by said introducing means into a selected site in a blood vessel; and said introducing means is an elongated removable core wire for insertion through said infusion lumen from said proximal end into said distal infusion segment for changing said expanded helical coil infusion configuration to allow the advancement of said infiision guidewire through the patient's vascular system to a desired site in a blood vessel, allowing said guidewire to be used to guide introduction of catheter devices over the guidewire, and allowing said distal infusion segment to assume said infusion configuration on removal of said catiieter device and witiidrawal of said core wire from said distal infusion segment. 13. The infusion device of Claim 1 wherein: said infusion device is formed as an infusion catheter adapted to be introduced by said introducing means into a desired infusion site in a blood vessel; and said introducing means is an elongated removable guidewire for insertion through said infiision lumen from said proximal end into said distal infusion segment for changing said infusion configuration to allow the advancement of said infusion catiieter through the patient's vascular system to a desired site in a blood vessel, and allowing said distal infusion segment to assume said infusion configuration on withdrawal of said guidewire from said distal infusion segment. 14. The infusion device of Claim 1 formed as an infusion catiieter and further comprising: a penetrable, self-sealing valve formed in said distal end of said elongated tubular body in alignment witii said infiision lumen; and wherein said introducing means further comprises: an elongated guidewire dimensioned to fit within said infiision lumen and extend tiirough said self-sealing valve, whereby said guidewire straightens said expanded helical coil infusion configuration to allow the advancement of said elongated tubular body tiirough the patient's vascular system over the guidewire to a desired infusion site in a blood vessel and said distal infusion segment is allowed to assume said expanded helical coil infusion configuration on withdrawal of said guidewire tiirough said self-sealing valve and from said distal infusion segment. 15. The infusion catheter of Claim 14 wherein said elongated tubular body further comprises: an elongated coiled wire extending from said proximal to said distal end and surrounding said infusion lumen, said elongated coiled wire pre-biased to form said helical coil infiision configuration in said distal infiision segment when said introducing means is witiidrawn from said distal infusion segment. 16. The infusion catheter of Claim 15 wherein said elongated tubular body further comprises: an elongated traction line attached to said elongated coiled wire distally to said distal infusion segment and operable from die proximal end of said elongated tubular body to apply tension along said distal infusion segment to urge die formation of said expanded helical coil infusion configuration upon withdrawal of said introducing means from said distal infusion segment and to adjust d e length of the helical coil infusion configuration. 17. The infusion catheter of Claim 14 wherein said elongated tubular body further comprises: an elongated coiled wire surrounding said infusion lumen in said distal infusion segment constructed of a temperature dependent memory material for assuming an expanded helical coil configuration when said introducing means is witiidrawn from said distal infusion segment and when exposed to a temperature change at a desired infusion site in a blood vessel to provide said centrally disposed blood perfusion lumen. 18. The infusion catheter of Claim 14 wherein said elongated tubular body further comprises: an elongated traction line attached to said elongated tubular body distal ly to said distal infusion segment and operable from d e proximal end of said elongated tubular body to apply tension to said distal infusion segment to urge the formation of said infusion configuration upon retraction of said core wire. 19. The infusion catiieter of Claim 14 wherein said distal infiision segment of said elongated tubular body further comprises: an elongated coiled wire surrounding said infusion lumen; an elongated sheath enclosing said elongated coiled wire for sealing said infusion lumen; and wherein: said plurality of infusion ports are formed as openings in said sheati in said distal infusion segment for allowing passage of said infusion fluid therethrough and into die low blood flow rate region of a blood vessel adjacent to the blood vessel wall.

Inventors: CRAGG M D ANDREW H, EVANS SCOTT M, WALLACE GEORGE B, CRAGG, M., D., ANDREW, H., EVANS, SCOTT, M., WALLACE, GEORGE, B.
Applicants: MICRO THERAPEUTICS INC, MICRO THERAPEUTICS, INC.
Application year: 1995
Main classification: A61M25
IPC codes: A61B17, A61M25